Pharmacokinetic Food-effect Study of Abiraterone Acetate (A.A) in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- Acronyms Abifood01
- 13 Nov 2017 Planned End Date changed from 1 Sep 2017 to 1 Jun 2018.
- 13 Nov 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Apr 2018.
- 10 Jun 2017 Biomarkers information updated